
FuelCell Energy (FCEL) Could Attract Short-Squeeze Speculation – FuelCell Energy (NASDAQ:FCEL)
It’s no secret that clean energy technology specialist FuelCell Energy Inc FCEL has thoroughly struggled this year, with FCEL stock ...

MYNA Investors Have Opportunity to Lead Mynaric AG Securities Fraud Lawsuit – Mynaric (NASDAQ:MYNA)
LOS ANGELES, Dec. 18, 2024 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with substantial losses ...

WBD Rises 20% in a Month: How Should You Play the Stock?
Warner Bros. Discovery WBD shares have soared 19.9% in a month, outperforming the Zacks Consumer Discretionary sector’s return of 4% ...
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Marqeta, Inc. (MQ) – Marqeta (NASDAQ:MQ)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 7, 2025 deadline to file a lead plaintiff ...

Top Buys by Top Brass: CEO McCarthy’s $107.8K Bet on DLX
A company’s own top management tend to have the best inside view into the business, so when company officers make ...

Best Value Stocks to Buy for December 18th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 18th: LATAM ...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Kyverna Therapeutics, Inc. (KYTX) Investors – Kyverna Therapeutics (NASDAQ:KYTX)
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has ...

Meet the 3 Artificial Intelligence (AI) Stocks Dan Ives Says Will Become The First Members of the $4 Trillion Club in 2025
As of the close of trading on Dec. 13, nine companies boasted market capitalizations of more than $1 trillion. In ...

FLUX Investors Have Opportunity to Lead Flux Power Holdings, Inc. Securities Fraud Lawsuit – Flux Power Holdings (NASDAQ:FLUX)
BENSALEM, Pa., Dec. 17, 2024 /PRNewswire/ — Law Offices of Howard G. Smith announces that investors with substantial losses have ...
Savara Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference – Savara (NASDAQ:SVRA)
Savara Inc. SVRA (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that the Company ...




